Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline response prediction in panic disorder
NL-OMON21722Active, not recruiting
- Sponsor
- Pfizer
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sertraline in panic disorder, sponsored by Pfizer. Primary endpoint: Baseline predictors of short-term and long-term sertraline response. Started Jun 2002; status: active, not recruiting.
02
Drugs
sertraline
03
Conditions
panic disorder
Beyond the preview
Go deeper on NL-OMON21722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21722.